ALB and hepatocellular carcinoma: Studies conducted by Lee et al. [66] and Fagenson et al. [67] revealed that a high pre-treatment serum ALB–BIL grade was independently correlated with greater early recurrence (≤1 year) and 30-day mortality in HCC patients undergoing curative surgical resection.